Cancer Institute A national cancer institute
designated cancer center

Gary Friedman

Publication Details

  • Risk of cancer in patients exposed to gabapentin in two electronic medical record systems PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Irizarry, M. C., Webb, D. J., Boudiaf, N., Logie, J., Habel, L. A., Udaltsova, N., Friedman, G. D. 2012; 21 (2): 214-225

    Abstract:

    High doses of gabapentin were associated with pancreatic acinar cell tumors in male Wistar rats, but there is little published epidemiological data regarding gabapentin and carcinogenicity. We explored the association between gabapentin and cancer in a US medical care program and followed up nominally significant associations in a UK primary care database.In the US Kaiser Permanente Northern California (KPNC) health system, we performed nested case-control analyses of gabapentin and 55 cancer sites and all cancers combined using conditional logistic regression. Up to 10 controls were matched to each case on year of birth, sex, and year of cohort entry. No other covariates were included in models. Only dispensings for gabapentin 2?years or more before index date were considered. Nominally significant associations with an OR?>?1.00 and p??1.00 and p?

    View details for DOI 10.1002/pds.2266

    View details for Web of Science ID 000299549600013

    View details for PubMedID 22144034

Stanford Medicine Resources:

Footer Links: